Intravenous contrast agents in diabetic patients taking metformin; an updated review on current concepts
Iodinated contrast agents are routinely used to diagnose a variety of diseases especially malignant tumors. They are crucial for accurate depiction of tumors, monitoring the response to treatment, and assessing possible recurrence of malignant lesions. Unfortunately, there are potential adverse effe...
Saved in:
Main Authors: | Masoumeh Asgharpour (Author), Rouzbeh Danialy (Author), Seyedhadi Mirhashemi (Author), Semko Ebrahimi (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nephroprotection and chemotherapy sensitivity impact of metformin during cisplatin therapy; an updated review
by: Mohsen Akhavan Sepahi, et al.
Published: (2019) -
Enteric and Intravenous Contrast Agents Used in Computed Tomography
by: Richard Burgner, et al.
Published: (2014) -
Administration of metformin in clinical medicine; an updated mini-review on current findings
by: Mahrang Hedaiaty
Published: (2018) -
Oral field cancerization: an update on current concepts
by: Meenakshi Mohan, et al.
Published: (2014) -
Lung cancer and kidney injury: an updated review
by: Bhargav Patel, et al.
Published: (2021)